Associates of Cape Cod Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project
PR92824
E. FALMOUTH, Mass., Nov. 5, 2021 /PRNewswire=KYODO JBN/ --
ACC proudly announces that it has achieved the release of its millionth
juvenile horseshoe crab to the wild, as a result of its species sustainability
project. The program is the first of its kind to release ecologically
significant numbers of North American Horseshoe Crabs (NAHSC); it was initiated
by the company in 2017 in the US and expanded into Asia in 2019, with a goal of
enhancing the sustainability of crab populations that are so vital to local
ecosystems as well as to the manufacture of Bacterial Endotoxin Test (BET)
reagents that utilize a raw material found in crab blood. ACC's reagents are
used worldwide in pharmaceutical, medical device, biotechnology, compounding
pharmacy and dialysis industries for quality control, product release and
research.
Video - https://www.youtube.com/watch?v=W36W2HxKT8I
Logo -
https://mma.prnewswire.com/media/1223081/Associates_of_Cape_Cod_Inc_Logo.jpg
With the goal of maintaining the greatest biodiversity possible, ACC's species
sustainability project sources NAHSC eggs and gametes exclusively from crabs
destined for terminal use as bait by the fishing industry. Without injury to
the crab, ACC staff harvest the reproductive cells, fertilize them in vitro and
then culture them to juvenile horseshoe crabs all within ACC's innovative,
patent pending aquaculture system at its facility in Falmouth, MA. Once the
crabs reach their first and second instars (about the size of a small
fingernail) the juveniles are released into the wild in a setting where they
can immediately burrow to safety.
"Our horseshoe crab sustainability project is important to the company and
other stakeholders of effected ecosystems," noted Dr. A.J. Meuse, President and
CEO of ACC, "This project aligns closely with our overall plans to minimize our
impact on the populations of the NAHSC and provided an opportunity to develop a
completely new aquaculture system technology specifically designed to support
the growth of horseshoe crabs. Local regulators supported our mission and
granted ACC a class 1 type 4 aquaculture permit that allowed us to make this
program a reality."
"The raising and releasing of more than a million horseshoe crabs into the
local ecosystems is expected to continue and have a measurable and positive
impact on horseshoe crab populations for years to come," said Brett
Hoffmeister, LAL Production Manager, ACC and author of the patent pending
aquaculture system. "As team leader, this incredible achievement would not have
been possible without the hard work and dedication of the ACC employees who
make up our horseshoe crab species sustainability team. We're excited to see
the impact that our program will have on our local aquatic ecosystem and
appreciate the vision of our corporate ownership who fully support our
efforts." Mr. Hoffmeister also commented that ACC's decision to provide these
highly specialized aquaculture systems free of charge to qualified academics in
Asia to support Tachypleus population recovery shows the company's dedication
to making a global impact.
ACC believes its incredibly successful horseshoe crab sustainability project is
the first to make an impact of this magnitude by any provider of Limulus
Ameobocyte Lysate (LAL) products. Since 2011, as an organization, ACC has
demonstrated its commitment to the environment and thoughtful use of resources
through other operational initiatives such as waste-water reduction and reuse
programs, packaging recycling practices, and the introduction of
environmentally friendly water-based glues and vegetable-based inks for
printing.
About Associates of Cape Cod Inc. -- A Seikagaku Group Company
Specializing in chromogenic and turbidimetric reagent technologies, Associates
of Cape Cod, Inc. (ACC) has been a global leader in endotoxin and
(1,3)-beta-D-glucans detection products and services for nearly 50 years. ACC
pioneered modern LAL testing methodology and was the first U.S. FDA licensed
company to manufacture LAL reagents; ACC is today recognized as an
international leader in endotoxin detection. Visit www.acciusa.com for more
information.
For further information contact
Vann Jones -- Senior Manager, Marketing
Associates of Cape Cod, Inc.
East Falmouth, MA 02536
USA
Phone: +1-888-395-2221
VJones@acciusa.com
www.acciusa.com
SOURCE Associates of Cape Cod Inc.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。